To date, many hematological markers can be used to monitor the disease progression of T2DM, such as serum glycated albumin (GA), glucose AC (fasting blood glucose), glycosylated hemoglobin (HbA1c), connecting peptide (C-peptide), and insulin antibodies (insulin Ab). Here, ALB is linked to type 2 diabetes mellitus.